Search Results

There are 3690 results for: content related to: The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010

  1. Novel therapeutics for type 2 diabetes: insulin resistance

    Diabetes, Obesity and Metabolism

    Volume 17, Issue 4, April 2015, Pages: 319–334, Q.-A. Altaf, A. H Barnett and A. A. Tahrani

    Version of Record online : 12 NOV 2014, DOI: 10.1111/dom.12400

  2. You have full text access to this OnlineOpen article
    Diabetes and cancer: two diseases with obesity as a common risk factor

    Diabetes, Obesity and Metabolism

    Volume 16, Issue 2, February 2014, Pages: 97–110, S. K. Garg, H. Maurer, K. Reed and R. Selagamsetty

    Version of Record online : 12 JUN 2013, DOI: 10.1111/dom.12124

  3. Current therapeutic interventions in the glycation pathway: evidence from clinical studies

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 8, August 2013, Pages: 677–689, L. Engelen, C. D. A. Stehouwer and C. G. Schalkwijk

    Version of Record online : 25 JAN 2013, DOI: 10.1111/dom.12058

  4. You have free access to this content
    The extra-pancreatic effects of GLP-1 receptor agonists: a focus on the cardiovascular, gastrointestinal and central nervous systems

    Diabetes, Obesity and Metabolism

    Volume 16, Issue 8, August 2014, Pages: 673–688, J. Seufert and B. Gallwitz

    Version of Record online : 16 JAN 2014, DOI: 10.1111/dom.12251

  5. Role of selective peroxisome proliferator-activated receptor modulators in managing cardiometabolic disease: tale of a roller-coaster

    Diabetes, Obesity and Metabolism

    Volume 16, Issue 9, September 2014, Pages: 780–792, A. Sahebkar and G. F. Watts

    Version of Record online : 11 MAR 2014, DOI: 10.1111/dom.12277

  6. Cardiovascular safety of sulfonylureas: a meta-analysis of randomized clinical trials

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 10, October 2013, Pages: 938–953, M. Monami, S. Genovese and E. Mannucci

    Version of Record online : 13 MAY 2013, DOI: 10.1111/dom.12116

  7. Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas

    Diabetes, Obesity and Metabolism

    Volume 18, Issue 4, April 2016, Pages: 333–347, C. F. Deacon and H. E. Lebovitz

    Version of Record online : 8 JAN 2016, DOI: 10.1111/dom.12610

  8. You have free access to this content
    Pharmacological interventions for preventing or delaying onset of type 2 diabetes mellitus

    Diabetes, Obesity and Metabolism

    Volume 17, Issue 3, March 2015, Pages: 231–244, M. A. Bethel, W. Xu and M. J. Theodorakis

    Version of Record online : 27 NOV 2014, DOI: 10.1111/dom.12401

  9. The role of glucagon-like peptide-1 impairment in obesity and potential therapeutic implications

    Diabetes, Obesity and Metabolism

    Volume 16, Issue 1, January 2014, Pages: 9–21, S. Madsbad

    Version of Record online : 26 MAY 2013, DOI: 10.1111/dom.12119

  10. Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles

    Diabetes, Obesity and Metabolism

    Volume 18, Issue 6, June 2016, Pages: 558–570, A. J. Krentz, K. Fujioka and M. Hompesch

    Version of Record online : 26 APR 2016, DOI: 10.1111/dom.12657

  11. You have free access to this content
    Plasticity of circadian clocks and consequences for metabolism

    Diabetes, Obesity and Metabolism

    Volume 17, Issue S1, September 2015, Pages: 65–75, C. P. Coomans, E. A. Lucassen, S. Kooijman, K. Fifel, T. Deboer, P. C. N. Rensen, S. Michel and J. H. Meijer

    Version of Record online : 1 SEP 2015, DOI: 10.1111/dom.12513

  12. Gastrointestinal actions of glucagon-like peptide-1-based therapies: glycaemic control beyond the pancreas

    Diabetes, Obesity and Metabolism

    Volume 18, Issue 3, March 2016, Pages: 224–235, M. M. Smits, L. Tonneijck, M. H. A. Muskiet, M. H. H. Kramer, D. L. Cahen and D. H. van Raalte

    Version of Record online : 5 JAN 2016, DOI: 10.1111/dom.12593

  13. Extra-pancreatic effects of incretin-based therapies: potential benefit for cardiovascular-risk management in type 2 diabetes

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 7, July 2013, Pages: 593–606, R. E. van Genugten, D. L. Möller-Goede, D. H. van Raalte and M. Diamant

    Version of Record online : 21 JAN 2013, DOI: 10.1111/dom.12050

  14. You have full text access to this OnlineOpen article
    Extracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?

    Diabetes, Obesity and Metabolism

    F. Prattichizzo, A. Giuliani, V. De Nigris, G. Pujadas, A. Ceka, L. La Sala, S. Genovese, R. Testa, A. D. Procopio, F. Olivieri and A. Ceriello

    Version of Record online : 22 JUN 2016, DOI: 10.1111/dom.12688

  15. You have full text access to this OnlineOpen article
    Review of head-to-head comparisons of glucagon-like peptide-1 receptor agonists

    Diabetes, Obesity and Metabolism

    Volume 18, Issue 4, April 2016, Pages: 317–332, Sten Madsbad

    Version of Record online : 29 DEC 2015, DOI: 10.1111/dom.12596

  16. You have free access to this content
    IRS2 integrates insulin/IGF1 signalling with metabolism, neurodegeneration and longevity

    Diabetes, Obesity and Metabolism

    Volume 16, Issue S1, September 2014, Pages: 4–15, M. F. White

    Version of Record online : 9 SEP 2014, DOI: 10.1111/dom.12347

  17. You have free access to this content
    Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus?

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 11, November 2013, Pages: 967–977, A. Consoli and G. Formoso

    Version of Record online : 18 APR 2013, DOI: 10.1111/dom.12101

  18. You have free access to this content
    Lost in translation: endoplasmic reticulum stress and the decline of β-cell health in diabetes mellitus

    Diabetes, Obesity and Metabolism

    Volume 15, Issue s3, September 2013, Pages: 159–169, C. Evans-Molina, M. Hatanaka and R. G. Mirmira

    Version of Record online : 4 SEP 2013, DOI: 10.1111/dom.12163

  19. Emerging immune therapies in type 1 diabetes and pancreatic islet transplantation

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 7, July 2013, Pages: 581–592, D. A. Schneider, A. M. Kretowicz and M. G. von Herrath

    Version of Record online : 21 JAN 2013, DOI: 10.1111/dom.12046

  20. You have full text access to this OnlineOpen article
    Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors

    Diabetes, Obesity and Metabolism

    Volume 18, Issue 3, March 2016, Pages: 203–216, M. Nauck

    Version of Record online : 5 JAN 2016, DOI: 10.1111/dom.12591